Metabolism of Moexipril to Moexiprilat: Determination of In Vitro Metabolism Using HPLC-ES-MS

Author(s): H. Kalasz, G. Petroianu, K. Tekes, I. Klebovich, K. Ludanyi, Zs. Gulyas

Journal Name: Medicinal Chemistry

Volume 3 , Issue 1 , 2007

Become EABM
Become Reviewer


Moexipril is a long-acting, non-sulfhydryl angiotensine-converting enzyme inhibitor. It is used for treatment of arterial hypertension. Moexipril is the prodrug, yielding moexiprilat by hydrolysis of an ethyl ester group. Moexiprilat is the metabolite responsible for the pharmacological effect after moexipril administration. Samples of rat and human microsomai preparations exposed to moexipril treatment were analyzed by HPLC using octyl silica stationary phase and isocratic elution. To detect moexipril and moexiprilat the separation was monitored by both ultraviolet and mass specific detection. The rat liver microsomal preparation was more effective to in producing moexiprilat than the similar one derived from human liver cell lines. While additional potential metabolites of moexipril were suggested by computer-modeling, moexiprilat was the sole metabolite detected after microsomal treatment.

Keywords: Moexipril metabolism, moexiprilat, microsomal, HPLC-ES-MS, isocratic elution

open access plus

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2007
Page: [101 - 106]
Pages: 6
DOI: 10.2174/157340607779317490

Article Metrics

PDF: 17